Cart summary

You have no items in your shopping cart.

Dapolsertib

SKU: orb2813910

Description

Dapolsertib (SEL24-B489) is an orally active, dual inhibitor of PIM kinases and FLT3-ITD. It reduces substrate phosphorylation and triggers apoptosis in leukemia cells in a dose-dependent manner. This compound is utilized in oncology research, showing activity in both cellular assays and in vivo models of hematological malignancies.

Research Area

Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction

Images & Validation

Key Properties

CAS Number1616359-00-2
MW446.14
Purity99.61% (May vary between batches)
FormulaC15H18Br2N4O2
SMILESO=N(=O)C=1C(Br)=C(Br)C=C2C1N=C(N2C(C)C)C3CCNCC3
TargetFLT,Apoptosis,Pim
SolubilityDMSO:15 mg/mL (33.62 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.48 mM)

Bioactivity

Target IC50
Pim2:2 nM (Kd)|Pim1:2 nM (Kd)|Pim3:3 nM (Kd)
In Vivo
Dapolsertib (25-100 mg/kg, orally) exhibited activity in AmL in vivo models . Dapolsertib induces apoptosis of DLBCL cell lines in low/sub-micromolar concentrations and exhibits activity in a xenograft model . Animal Model: SCID/beige mice bearing MV-4-11 tumors (FLT3-ITD+) . Dosage: 50, 75 and 100 mg/kg. Administration: Orally, twice daily. Result: Marked dose – dependent tumor reduction (67%, 74% and 82% tumor growth inhibition (TGI) for 50, 75 and 100 mg/kg daily doses, respectively).
In Vitro
In MOLM-13 and to a lesser extent in MV4-11 cells, a dose-dependent disruption of cell cycle with especially pronounced depletion of the S phase after treatment with Dapolsertib, accompanied by PARP cleavage and apoptosis was observed . Dapolsertib causes a profound inhibition of S6 (S 235/236 ), but has little effect on PI3K/mTOR signaling . Dapolsertib inhibits STAT5 (Ser 726 ) and reduced expression of MCL1, whereas none of the selective inhibitors altered c-MYC abundance or induced PARP cleavage . Cell Viability Assay Cell Line: AZD1208, AC220 and AraC in AmL cell lines. Concentration: 0-10 μM. Incubation Time: 72 h. Result: Decreased viability.

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

SEL-24-B489, SEL24-B489, SEL24-B-489, SEL 24-B489, SEL24 B489, SEL24-B 489, SEL24B489, MEN1703, MEN 1703
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Dapolsertib (orb2813910)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 110.00
5 mg
$ 200.00
10 mg
$ 290.00
25 mg
$ 440.00
50 mg
$ 610.00
100 mg
$ 830.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry